GCDFP-15 has also been described in detail elsewhere (6). Briefly, BALB/c mice were immunized intraperitoneally with 100 pg ofpurified GCDFP-15 at 14-day intervals. Three days before fusion, the mice were injected intra- Figure 4) . When the percentage of positive-staining carcinoma cells was evaluated with the monoclonal antibodies vs the rabbit antiserum, the results were equivalent (see Table 6 ).
Of the 30 cases of breast carcinoma with apocnine featunes, 19 (63%) stained positively ( There was no staining in the one case ofmucoid carcinoma.
Discussion
We have previously shown, using rabbit polyclonal antiserum, that the normal tissue localization ofthe GCDFP-15 protein is predominantly in association with apocnine glands (4). The GCDFP-1S protein used for immunization of the rabbits was isolated from human breast gross cystic disease fluid (2). By RIA criteria with rabbit antiserum, we have been unable to show any antigenic variability have deleted some of these determinants. We therefore undertook an immunopenoxidase staining study to answer this question. The normal tissues that express GCDFP-15 are the apocnine glands and the serous cells of submandibular salivary glands (4). In both of these tissues the monoclonal antibody staining patterns were identical (see Table 2 ). With regard to carcinoma tissue, 40 breast cancinomas were studied for GCDFP-1S expression ('I#{224}ble 5), as well as normal tissues and carcinomas from 13 organ sites previously shown by rabbit antiserum not to express GCDFP-1S (Table 4) . In all of the tested tissue, monoclonal detection or nondetection of GCDFP-15 was uniform and was essentially identical to that of the rabbit polyclonal antibody. These findings support the hypothesis that GCDFIMS does not show epitope variation for monoclonal-detected epitopes of D6, Bi, and B4 in the various tissues studied.
Our results support the use of any of these three monoclonal 
